Suppr超能文献

酶清创术与标准烧伤护理的经济学分析:一项回顾性分析。

ECONOMIC ANALYSIS OF ENZYMATIC DEBRIDEMENT VERSUS STANDARD BURN CARE: A RETROSPECTIVE ANALYSIS.

作者信息

Minic J, Vestita M, Vigato E, Dallapozza E, Shoham Y, Lavagnolo U, Bianchi F P, Fratucello A, Governa M

机构信息

Department of Plastic and Reconstructive Surgery and Burn Unit, University Hospital, Verona, Italy.

Department of Plastic and Reconstructive Surgery and Burn Unit, A. Perrino Hospital, Brindisi, Italy.

出版信息

Ann Burns Fire Disasters. 2024 Jun 30;37(2):148-158. eCollection 2024 Jun.

Abstract

When compared to standard surgical management, rapid enzymatic debridement of deep burns reduces the need for surgery while achieving similar long-term results. However, few studies have directly compared the costs of standard surgical and enzymatic burn care. We conducted a study comparing the care costs of 44 adult burn patients treated before (n=22) and after (n=22) introducing rapid bromelain-based enzymatic debridement (BED) of deep burns. Mean age was 59 years, 54% were male, and mean total body surface area (TBSA) was 23.5%. Burn etiology included flame and scalding burns (8). Groups treated with standard of care and enzymatic debridement were comparable in terms of age, sex and TBSA. Burn management with BED significantly reduced total debridement costs as well as grand total costs when compared with traditional surgical care. Such reduction was mostly related to lower costs associated with reduced surgical care and less facilities and resources consumption in the BED group.

摘要

与标准手术治疗相比,深度烧伤的快速酶清创术在取得相似长期效果的同时,减少了手术需求。然而,很少有研究直接比较标准手术和酶法烧伤治疗的费用。我们进行了一项研究,比较了44例成年烧伤患者在引入基于菠萝蛋白酶的深度烧伤快速酶清创术(BED)之前(n = 22)和之后(n = 22)的护理费用。平均年龄为59岁,54%为男性,平均总体表面积(TBSA)为23.5%。烧伤病因包括火焰和烫伤(8例)。接受标准护理和酶清创术治疗的组在年龄、性别和TBSA方面具有可比性。与传统手术护理相比,BED烧伤管理显著降低了总清创成本以及总费用。这种降低主要与BED组因减少手术护理以及较少的设施和资源消耗而产生的较低成本有关。

相似文献

1
ECONOMIC ANALYSIS OF ENZYMATIC DEBRIDEMENT VERSUS STANDARD BURN CARE: A RETROSPECTIVE ANALYSIS.
Ann Burns Fire Disasters. 2024 Jun 30;37(2):148-158. eCollection 2024 Jun.
4
A novel rapid and selective enzymatic debridement agent for burn wound management: a multi-center RCT.
Burns. 2014 May;40(3):466-74. doi: 10.1016/j.burns.2013.08.013. Epub 2013 Sep 26.
6
The use of NexoBrid™ enzymatic debridement and coagulation abnormalities.
Burns. 2024 Feb;50(1):123-131. doi: 10.1016/j.burns.2023.06.012. Epub 2023 Jul 7.
7
Enzymatic debridement for circumferential deep burns: the role of surgical escharotomy.
Burns. 2023 Mar;49(2):304-309. doi: 10.1016/j.burns.2022.12.003. Epub 2022 Dec 17.
8
Early experiences using bromelain-based enzymatic debridement in a tertiary burns centre in the United Kingdom: A retrospective case series review.
J Plast Reconstr Aesthet Surg. 2021 Jun;74(6):1402-1407. doi: 10.1016/j.bjps.2020.12.028. Epub 2020 Dec 15.
10
Safety of enzymatic debridement in extensive burns larger than 15% total body surface area.
Burns. 2021 Jun;47(4):796-804. doi: 10.1016/j.burns.2020.10.012. Epub 2020 Oct 25.

引用本文的文献

本文引用的文献

1
Italian recommendations on enzymatic debridement in burn surgery.
Burns. 2021 Mar;47(2):408-416. doi: 10.1016/j.burns.2020.07.006. Epub 2020 Jul 15.
2
Eschar removal by bromelain based enzymatic debridement (Nexobrid®) in burns: European consensus guidelines update.
Burns. 2020 Jun;46(4):782-796. doi: 10.1016/j.burns.2020.03.002. Epub 2020 Mar 30.
3
Cost Analysis of a Novel Enzymatic Debriding Agent for Management of Burn Wounds.
Biomed Res Int. 2017;2017:9567498. doi: 10.1155/2017/9567498. Epub 2017 Feb 15.
5
A novel rapid and selective enzymatic debridement agent for burn wound management: a multi-center RCT.
Burns. 2014 May;40(3):466-74. doi: 10.1016/j.burns.2013.08.013. Epub 2013 Sep 26.
6
7
State of the art in burn treatment.
World J Surg. 2005 Feb;29(2):131-48. doi: 10.1007/s00268-004-1082-2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验